Cardiovascular Systems (CSII) Tops Q2 EPS by 3c, Offers Q3 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Cardiovascular Systems Reports Fiscal 2016 Second-Quarter Financial Results
January 21, 2016 4:05 PM ESTConference Call Scheduled for Today, January 21, 2016, at 3:45 PM CT (4:45 PM ET)
Revenues of $41.4 million were 3% below the guidance range due to continued effects of the sales force transition Gross margin increased to 80.5%, primarily benefiting from lower unit costs Net loss of $(0.47) per share was favorable to guidance, primarily as a result of cost reductions LIBERTY 360° enrollment nears completion, demographic data to be presented at ISET as a late-breaking presentation COAST 30-day... More